Month: January 2026

Erasca Announces Pricing of Upsized Public Offering of Common Stock

Written by Customer Service on January 22, 2026. Posted in Public Companies.

SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an upsized public offering of 22,500,000 shares of its common stock. The shares of common stock are being sold to the public at a price of $10.00 per share. All of the shares of common stock to be sold in the public offering are to be sold by Erasca. The gross proceeds to Erasca from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $225.0 million. In addition, Erasca has granted the underwriters a 30-day option to purchase up to an additional 3,375,000 shares of common stock at the offering...

Reflex Advanced Announces Private Placement Offering

Written by Customer Service on January 22, 2026. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 21, 2026 (GLOBE NEWSWIRE) — Reflex Advanced Materials Corp. (CSE:RFLX) (FSE:HF2) (“Reflex” or the “Company”), is pleased to announce that it intends to complete a non-brokered private placement offering of units of the Company (“Units”), at a price of C$0.175 per Unit, for aggregate gross proceeds of up to C$200,000. Each Unit will be comprised of one common share of the Company (each, a “Share”) and one Share purchase warrant (“Warrants”), with each Warrant entitling the holder to acquire one Share (each, a “Warrant Share”) at a price of C$0.23 for a period of 24 months. The Company intends to use the net proceeds raised from the Offering for working capital and general corporate purposes. All securities...

Telesat Statement on Creditor Litigation

Written by Customer Service on January 22, 2026. Posted in Public Companies.

OTTAWA, Ontario, Jan. 21, 2026 (GLOBE NEWSWIRE) — Telesat (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, confirms that certain creditors holding portions of the company’s legacy GEO (Geostationary Earth Orbit) debt have filed lawsuits in both New York and Ontario regarding the equity distribution in September 2025 of the Telesat Lightspeed business. The lawsuits, filed at the direction of a group of distressed debt hedge funds, are without merit. The equity distribution at issue followed a robust governance process and was accomplished in strict accordance with relevant debt agreements and applicable law. Telesat intends to defend itself vigorously. Telesat and its stakeholders are firmly committed to supporting the company’s customers, advancing the Telesat Lightspeed program, and creating...

Rocket Lab Neutron Test Update

Written by Customer Service on January 22, 2026. Posted in Public Companies.

LONG BEACH, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced an update relating to the development of its Neutron rocket. As the Company pushes Neutron to the limits and beyond to qualify its systems and structures for launch, qualification testing of the Stage 1 tank overnight resulted in a rupture during a hydrostatic pressure trial. Testing failures are not uncommon during qualification testing. We intentionally test structures to their limits to validate structural integrity and safety margins to ensure the robust requirements for a successful launch can be comfortably met. There was no significant damage to the test structure or facilities, the next Stage 1 tank is already in production, and...

Crown Castle Announces Tax Reporting Information for 2025 Distributions

Written by Customer Service on January 21, 2026. Posted in Dividend Reports And Estimates.

HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today certain year-end tax reporting information for its 2025 distributions. The following table summarizes, for income tax purposes, the nature of distributions paid to holders of Crown Castle Common Stock, par value $.01 per share (“Common Stock”), presented on a per share basis, during the calendar year ended December 31, 2025. Stockholders are urged to consult with their personal tax advisors as to their specific tax treatment of Crown Castle’s distributions. Crown Castle Common StockTicker Symbol: CCICUSIP 22822V101Record Date Payment Date Cash Distribution (per share) Ordinary TaxableDividend(per share) Qualified Taxable Dividend(per share)* Section 199A Dividend(per share)* Non-Taxable Distribution (per share)3/14/2025 3/31/2025 $1.565000 $1.292363 $0.029189 $1.263174 $0.2726376/13/2025 6/30/2025 $1.062500 $0.877403 $0.019817 $0.857586 $0.1850979/15/2025 9/30/2025 $1.062500 $0.877403 $0.019817 $0.857586 $0.18509712/15/2025 12/31/2025 $1.062500 $0.877403 $0.019817 $0.857586 $0.185097*Qualified...

Safeguard Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about January 26, 2026

Written by Customer Service on January 21, 2026. Posted in Public Companies.

LAS VEGAS, NV, Jan. 21, 2026 (GLOBE NEWSWIRE) — Safeguard Acquisition Corp. (NYSE: SAC.U) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriters of their overallotment option in full, completed on December 5, 2025 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about January 26, 2026. Any units not separated will continue to trade on the New York Stock Exchange under the symbol “SAC.U,” and each of the Class A ordinary shares and warrants will separately trade on the New York Stock Exchange under the symbols “SAC” and “SAC WS,” respectively. No fractional warrants will be issued upon separation of the units...

Great Southern Bancorp, Inc. Reports Preliminary Fourth Quarter Earnings of $1.45 Per Diluted Common Share

Written by Customer Service on January 21, 2026. Posted in Earnings Releases And Operating Results.

Preliminary Financial Results and Business Update for the Quarter and Year Ended December 31, 2025 SPRINGFIELD, Mo., Jan. 21, 2026 (GLOBE NEWSWIRE) — Great Southern Bancorp, Inc. (the “Company”) (NASDAQ:GSBC), the holding company for Great Southern Bank (the “Bank”), today reported that preliminary earnings for the three months ended December 31, 2025, were $1.45 per diluted common share ($16.3 million net income) compared to $1.27 per diluted common share ($14.9 million net income) for the three months ended December 31, 2024. Full-year preliminary earnings for 2025 were $71.0 million, or $6.19 per diluted common share, compared to $61.8 million, or $5.26 per diluted common share, for 2024. For the quarter ended December 31, 2025, annualized return on average common equity was 10.16%, annualized return on average assets was 1.16%,...

Kimco Realty Corporation Announces 2025 Dividend Tax Treatment

Written by Customer Service on January 21, 2026. Posted in Dividend Reports And Estimates.

JERICHO, N.Y., Jan. 21, 2026 (GLOBE NEWSWIRE) — Kimco Realty® (NYSE: KIM), a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, announced today the 2025 tax treatment of its common stock and preferred stock dividend distributions. The allocations as they will be reported on Form 1099-DIV are as follows:Common Shares (CUSIP # 49446R-10-9) Ex- Ordinary Income Capital Gains Dividend Record Payable Distribution Non- Unrecaptured Return of Sec 199A Date Date Date per Share Total Qualified Qualified Total Sec 1250 Capital Dividends 03/07/2025 03/07/2025 03/21/2025 $0.250000 $0.244861 $0.243514 $0.001347 $0.003723 $0.003686 $0.001416 $0.243514 06/06/2025 06/06/2025 06/20/2025 $0.250000 $0.244861 $0.243514 $0.001347 $0.003723 $0.003686 $0.001416 $0.243514 09/05/2025 09/05/2025 09/19/2025 $0.250000 $0.244861 $0.243514 $0.001347 $0.003723 $0.003686 $0.001416 $0.243514 12/05/2025 12/05/2025 12/19/2025 $0.260000 $0.254655 $0.253254 $0.001401 $0.003872 $0.003834 $0.001473 $0.253254 Totals $1.010000 $0.989238 $0.983796 $0.005442 $0.015041 $0.014892 $0.005721 $0.983796 100.0000% 97.406% 0.539% 1.489% 1.474% 0.566% Preferred...

GBank Appoints Jason Amos as Executive Vice President and Chief Technology Officer

Written by Customer Service on January 21, 2026. Posted in Public Companies.

LAS VEGAS, Jan. 21, 2026 (GLOBE NEWSWIRE) — GBank Financial Holdings Inc. (the “Company”) (Nasdaq: GBFH), the parent company of GBank (the “Bank”), is pleased to announce that Jason Amos has been appointed Executive Vice President and Chief Technology Officer (EVP & CTO) of the Bank. Amos will lead the bank’s technology strategy and modernization efforts as GBank advances toward a digital-first operating model. Amos brings more than twenty years of experience building and leading large-scale technology platforms across global enterprises including Microsoft, Intel Security (McAfee), and Dell, as well as serving as Chief Technology Officer for multiple technology and fintech ventures. His background spans cloud platforms, cybersecurity, payments infrastructure, and emerging financial technologies. In his role, Amos will oversee...

BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business

Written by Customer Service on January 21, 2026. Posted in Mergers And Acquisitions.

Accelerates expansion of BioStem’s commercial organization through integration of an experienced national sales force Expands access to major GPO networks, strengthening BioStem’s position across hospital settings Barry Hassett promoted to Chief Commercial Officer Conference call scheduled for tomorrow, January 22nd at 8am ET POMPANO BEACH, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the closing of a definitive asset purchase agreement with BioTissue Holdings Inc, a pioneer and leader in regenerative healing, whereby BioStem acquired the BioTissue surgical and wound care business. BioTissue is an ocular-first biotechnology leader, pioneering...

Month: January 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals